Compared with healthy donors, circulating T cells from CLL patients have been shown to have elevated PD-1 expression that is further upregulated upon in vitro T cell activation via CD3/CD28 [58,59]. The gene discussed is PDCD1; the disease is B-cell chronic lymphocytic leukemia.